NALT

Preferred term

Mavacoxib

Mavacoxib is a member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3 and 5 by 4-sulfamoylphenyl, trifluoromethyl and 4-fluorophenyl groups, respectively. A selective cyclooxygenase 2 inhibitor, it is used in veterinary medicine to treat pain and inflammation in dogs with degenerative joint disease. It has a role as a non-steroidal anti-inflammatory drug, a cyclooxygenase 2 inhibitor and a non-narcotic analgesic. It is a sulfonamide, an organofluorine compound and a member of pyrazoles. [Okay'd by Liz]

nonsteroidal anti-inflammatory agents

Field 001 in MARC Authority Format

21165407

Spanish

mavacoxib

URI

https://lod.nal.usda.gov/nalt/21165407

Download this concept

Created 4/3/23, last modified 5/4/24